Cerecor sells 5 products, sales force to focus on rare diseases

A Rockville biopharmaceutical company is selling five pediatric product lines and sales force to a Colorado firm in a deal worth more than $43 million so it can focus more on developing potentially lucrative treatments for rare diseases.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *